Safety of AZD1222 COVID19 vaccine and low Incidence of SARSCoV2 infection in Botswana following ChAdOx1AZD1222 vaccination A singlearm openlabel interventional study final study results

Abstract

Description

Keywords

Citation

SCOPUS

Endorsement

Review

Supplemented By

Referenced By